Yating You

Ms. Yating You


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
YYYating You
Yating You
XLXiaoheng Li
Xiaoheng Li
BCBinglin Chen
Binglin Chen
XZXuan Zou
Xuan Zou
GLGang Liu
Gang Liu
XHXinxin Han
Xinxin Han
Influenza is prevalent globally, leading to severe morbidity and mortality. During the pandemic, knowledge, attitude, and practice (KAP) towards influenza virus and vaccination were less investigated among southern Chinese older adults. A cross-sectional study was conducted through the structured questionnaire among community healthcare centers in selected districts in Shenzhen, southern China from September to October 2021. KAP towards influenza virus and vaccination were analyzed. A multivariable logistic regression model was used to identify associated factors. Among 975 participants, 55.6% were reported to have received influenza vaccination ever, and 46.6% had taken influenza vaccination in 2020 during the pandemic. Only one-fifth of participants knew severe comorbidities happen among severe influenza cases. A total of 88.3% thought older adults should have influenza vaccination. COVID-19 vaccination history was associated with receiving influenza vaccination (OR 1.92, 95% CI 1.32–2.80). People with a high-level income had better KAP towards influenza virus and vaccination. COVID-19 vaccination history was associated with the positive actions of influenza vaccination during the pandemic. Efforts should be made to promote the free influenza vaccination program widely and launch health education events on influenza and its vaccination regularly to improve KAP among older adults.

16 April 2025 in The Journal Of Prevention of Alzheimer's Disease
Verified
Journal Article
Open access
YZYaguan Zhou
Yaguan Zhou
YYYating You
Yating You
YZYuting Zhang
Yuting Zhang
YZYue Zhang
Yue Zhang
CYChangzheng Yuan
Changzheng Yuan
XXXiaolin Xu
Xiaolin Xu
Chronic diseases (e.g., hypertension, diabetes, and heart diseases) have been proposed as marked predictors of incident dementia. However, synthesised evidence on the effect of multimorbidity on dementia is still lacking. We aim to summarise the association between multimorbidity and risk of dementia in longitudinal cohorts. In this systematic review and meta-analysis, we conducted a systematic search in PubMed, Web of Science and Embase from inception to Dec 14, 2024, to identify longitudinal cohort studies reporting the association between multimorbidity or multimorbidity patterns and risk of dementia. Information of included studies were extracted by three reviewers (YaZ, YY and YuZ), and the quality assessment was conducted using the Newcastle-Ottawa Scale. The inverse-variance weighted random effects meta-analysis was performed to obtain the pooled hazard ratios (HRs) and 95 % confidence intervals (CIs) for dementia associated with multimorbidity and cardiometabolic multimorbidity (CMM). Cochran's Q test and the I2 statistic were used to indicate heterogeneity among the studies. Meta-regression analysis, subgroup analysis and sensitivity analysis were conducted to determine any valid sources of heterogeneity. This study was registered with PROSPERO (CRD42023403684). We included 17 longitudinal cohort studies (2262,885 middle-aged and older participants) in the systematic review, of which seven were included in meta-analysis. All studies presented moderate to high methodological quality. Meta-analysis showed a positive association between multimorbidity and incident dementia (HR=1.53, 95 % CI=1.12 to 2.09), with substantial heterogeneity (I2=95.2 %). Studies using health records to measure dementia tend to find a stronger positive relationship between multimorbidity and risk of dementia than those using self-report (HRhealth records=1.94, 95 % CI=1.35 to 2.78, I2=94 %; HRself-report=1.17, 95 % CI=1.07 to 1.28, I2=0 %). The impacts of CMM were also observed, and the HRs for dementia ranged from 2.49 (combination of heart diseases and stroke: 95 % CI=1.64 to 3.78) to 3.77 (combination of diabetes, heart diseases and stroke: 95 % CI=2.02 to 7.02). The heterogeneity was moderate, with I2 ranging from 46.9 % (p for heterogeneity=0.152) to 84.1 % (p for heterogeneity=0.002). The impacts of number of diseases, multimorbidity clusters, and multimorbidity trajectory on risk of dementia were narratively summarised due to lacking comparable studies. Limited evidence (only one study) precluded quantitative synthesis for the association of physical and psychological multimorbidity with dementia. Multimorbidity and CMM pattern were significantly associated with risk of dementia, while the effect of physical and psychological multimorbidity remain inconclusive. Individuals affected by multimorbidity should be prioritised in risk factor modification and dementia prevention. Preventing the development of multimorbidity is also crucial-particularly those who already have one chronic disease-in order to maintain cognitive health.

1 September 2025 in Brain Communications
Verified
Journal Article
Open access
YYYating You
Yating You
JWJoey Ward
Joey Ward
FHFrederick K Ho
Frederick K Ho
DLDonald M Lyall
Donald M Lyall
Claire E HastieClaire E Hastie
Claire E Hastie
Apolipoprotein E gene (APOE) e4 allele is known as the strongest common genetic risk factor for Alzheimer’s disease. Various lifestyle factors are reported to have multiple associations with brain health, including smoking, alcohol intake, diet, sedentary behaviour and physical activity. However, the associations and interactions of overall or individual modifiable lifestyle factors and APOE e4 genotype, on brain volumes and white matter tract integrity measured by diffusion tensor imaging and neurite orientation dispersion and density imaging (NODDI), remain incompletely understood. In this cross-sectional study, we used data from the UK Biobank MRI assessment (N = 24 912) participants living without dementia. They were classified as having ‘favourable’, ‘moderate’ and ‘unfavourable’ levels based on their lifestyle scores (0–10 points) being calculated by the magnitudes of adherence to five healthy lifestyle guidelines: two points for each healthy category, one point for moderate ones, and zero point for unhealthy ones. Neuroimaging markers, namely brain volumes and white matter tract integrity measures, were derived from MRI. Linear regression was performed to examine the associations and interactions of lifestyle levels, APOE e4 genotype and each lifestyle factor, with multiple brain structural MRI phenotypes. We found that compared with favourable-level lifestyle, moderate and unfavourable levels were significantly independently associated with smaller grey matter, hippocampus and total brain volumes (standardized β range 0.004–0.096 per unit). Significant associations were found between APOE e4 presence and smaller hippocampal volumes (β range 0.042–0.048 lower versus absence) and worse white matter tract integrity. Individual unhealthy lifestyle aspects were mostly associated with poorer brain structural markers, such as current smoking (β range −0.014 to 0.209), high-level drinking (β range −0.105 to 0.152) and grey matter and white matter, as well as both traditional white matter tract and NODDI metrics, in both individually and simultaneously modelled lifestyle-factor models. The interactions between lifestyle levels and APOE e4 status on brain metrics were generally non-significant. In conclusion, the presence of APOE e4 and non-favourable lifestyles were mostly associated with worse brain health, and this was largely linear rather than synergistic. The benefit of a healthy lifestyle on brain health does not vary by genetic risk for dementia.

1 December 2025 in PsyArXiv
Verified
Preprint
Open access
YYYating You
Yating You
LLLaura Lyall
Laura Lyall
FHFrederick K. Ho
Frederick K. Ho
CHClaire Hastie
Claire Hastie
DLDonald M Lyall
Donald M Lyall
Background and Objectives: Modifiable lifestyle behaviours associated with brain health include smoking, diet, alcohol intake, sedentary behaviour and physical inactivity. However, longitudinal evidence on their contributions to structural brain atrophy, considering APOE e4 risk, in populations living without dementia remains scarce. Methods: In the UK Biobank, lifestyle scores were calculated based on the above five lifestyle behaviours at initial MRI assessment. Participants were classified into unfavourable (0-3 ‘points’), moderate (4-6) and favourable (7-10) lifestyle groups. Structural change phenotypes were calculated from two brain MRI assessments over the median follow-up of 2.3 years (up to seven years). Linear regression models were applied to estimate associations between lifestyle and structural changes in 15 brain imaging markers, and their potential interactions with APOE e4 genotype. Results: Among 3224 participants living without dementia who underwent two scans (median follow-up = 2.25 years), unfavourable lifestyle was associated with 28.9 mm3 greater atrophy in the left hippocampus, equivalent to 0.041 standard deviations (SD) greater loss (P=0.048; versus ‘favourable’). APOE e4 carriers showed 24.7 mm3 greater left hippocampal atrophy (0.049 SDs, p(FDR)=0.030) and 195.3 mm3 greater grey matter loss in the frontal pole (0.050 SD, p(FDR)=0.030) versus non-carriers. Compared with high levels of physical activity, low (unstandardised beta=0.049, 0.038 SDs, P=0.038) and medium (unstandardised beta=0.054, 0.043 SDs, P=0.022) levels showed greater increase in white matter hyperintensities (WMH) volumes. No interactions were observed between lifestyle and APOE e4 on brain atrophy.Discussion: Lifestyle and genetic risk contribute to longitudinal brain atrophy, with unfavourable lifestyle, specifically less physical activity, and APOE e4 associated with greater hippocampal atrophy and WMH burden. Promoting a healthy lifestyle, particularly more physical activity, may help slow brain structural decline and delay cognitive ageing regardless of genetic risk.

23 July 2026 in PsyArXiv
Verified
Preprint
Open access
YYYating You
Yating You
FHFrederick K. Ho
Frederick K. Ho
DLDonald M Lyall
Donald M Lyall
CHClaire Hastie
Claire Hastie
INTRODUCTIONLittle is understood about the extent to which lifestyle factors can advance or delay the risk of developing dementia, and whether that is dependent on non-modifiable factors, e.g. sex and genetic susceptibility.METHODSAmong 224,516 UK Biobank participants aged ≥50 years at baseline, Cox regression examined the relations of apolipoprotein E gene (APOE) genotypes, and lifestyle with incident dementia. Rate advancement periods were used to quantify the association between these factors and advancing or delaying incidence rate relative to age.RESULTSOver median follow-up of 13.6 years, versus neutral APOE ε3ε3, ε4 presence advanced dementia risk by 5.58 years whereas ε2 presence delayed by 1.08 year (q<0.001). Overall unfavourable lifestyle advanced dementia risk by 1.90 years - specifically, smoking, heavy drinking, and prolonged sedentariness, by 0.64 to 1.52 years (q<0.001). Interactions showed that overall unfavourable lifestyle advanced more dementia risk more among ε2 carriers than ε4 carriers, and ε4 presence advanced more in females than males.DISCUSSIONOverall unfavourable lifestyle and APOE ε4 genotype advanced dementia risk independently by almost 2 and 6 years respectively, with significant gene-lifestyle and gene-sex interactions. Lifestyle’s benefit on cognitive preservation is to some extent sex and genotype-specific, which targeted intervention does not currently consider.

1 July 2026 in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Verified
Journal Article
Open access
PDF file
YYYating You
Yating You
LLLaura M. Lyall
Laura M. Lyall
FHFrederick K. Ho
Frederick K. Ho
CHClaire E. Hastie
Claire E. Hastie
DLDonald M. Lyall
Donald M. Lyall
INTRODUCTION: The associations of modifiable daily lifestyle variables (e.g., smoking, diet, alcohol intake, sedentary behavior, and physical activity) with structural brain atrophy, and interaction with apolipoprotein E ( APOE) ε4 genetic risk, remain unclear. METHODS: Among 3265 UK Biobank participants with repeated magnetic resonance imaging (MRI) data (mean follow‐up 2.6 years), we assessed the relations between lifestyle, APOE ε4 genotype, and volumetric changes in 15 structural brain phenotypes, using linear regression. RESULTS: APOE ε4 presence showed greater atrophy by 25.1 mm 3 in the left hippocampus ( β : −0.115 standard deviations, 95% confidence interval [CI] [−0.192, −0.039] and 187.7 mm 3 in frontal pole gray matter ( β : −0.112, 95% CI [–0.186, −0.039]) ( q  < 0.05). Unfavorable lifestyle accelerated left hippocampal atrophy, and smoking increased white matter hyperintensity volumes ( q  > 0.05). No interactions were observed. DISCUSSION: Our study reinforces the independent effect of APOE ε4 on longitudinal brain atrophy. Lifestyle may help preserve structural brain health, and our findings provide no evidence this varies by APOE ε4 genotype.